U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CERVARIX COMPONENT HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN
Preferred Name English
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN
Common Name English
HPV-16 L1 TRUNCATED VLP ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS BIVALENT (TYPES 16 AND 18) VACCINE, RECOMBINANT COMPONENT HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN
Common Name English
Code System Code Type Description
FDA UNII
7XB76X2V7T
Created by admin on Mon Mar 31 18:16:37 GMT 2025 , Edited by admin on Mon Mar 31 18:16:37 GMT 2025
PRIMARY
DRUG BANK
DB10994
Created by admin on Mon Mar 31 18:16:37 GMT 2025 , Edited by admin on Mon Mar 31 18:16:37 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966